Merck's Phase 3 trial of Keytruda plus chemo met progression-free survival and overall survival goals in platinum-resistant ...

Merck, a leading science and technology company, today launched its global 2025 Curiosity Cube tour in Darmstadt, Germany. The solar-powered mobile science labs will bring hands-on STEM (science ...

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...

Merck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer. | ...

Merck has received approval from the Food and Drug Administration for Welireg, its oral inhibitor for patients with certain rare types of neuroendocrine tumors. The company said Wednesday the ...

Merck has launched its 2025 Curiosity Cube tour, bringing hands-on STEM experiences to students across the world.

Kansas Gov. Laura Kelly announced that Merck Animal Health will build an $895 million capital expansion project and add 200 ...

A new manufacturing plant in De Soto will be a Center of Excellence for the global company, along with expanded R&D ...

DE SOTO, Kan. (KCTV) - Merck Animal Health is betting big on De Soto, announcing an $895 million expansion Thursday that ...

TOPEKA — Merck Animal Health will build an $895 million capital expansion project and add 200 jobs at its De Soto ...

Merck Animal Health announced on Thursday morning that it plans to invest $895 million in the expansion of its biologics facility in De Soto.

Merck Animal Health plans to spend $895 million to expand the company’s manufacturing, research and development campus in De ...